CIMEIO THERAPEUTICS Trademark

Trademark Overview


On Friday, April 22, 2022, a trademark application was filed for CIMEIO THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the CIMEIO THERAPEUTICS trademark a serial number of 79342996. The federal status of this trademark filing is REGISTERED as of Tuesday, December 19, 2023. This trademark is owned by CIMEIO THERAPEUTICS AG. The CIMEIO THERAPEUTICS trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical products for gene and cell therapy

Gene and cell therapy medical services; medical consultant services in the fields of gene therapy and cell therapy

Pharmaceutical research and development services in the fields of gene therapy and cell therapy; medical and pharmaceutical research and development services, all in the fields of gene therapy and cell therapy; research services relating to pharmaceutical products for gene and cell therapy; biochemistry research services relating to cell therapy and gene therapy
cimeio therapeutics

General Information


Serial Number79342996
Word MarkCIMEIO THERAPEUTICS
Filing DateFriday, April 22, 2022
Status700 - REGISTERED
Status DateTuesday, December 19, 2023
Registration Number7244974
Registration DateTuesday, December 19, 2023
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 3, 2023

Trademark Statements


Description of MarkThe mark consists of a stylized triangle design with a circle in the middle and the stylized wording "CIMEIO THERAPEUTICS".
Goods and ServicesPharmaceutical products for gene and cell therapy
Translation of Words in MarkThe wording "CIMEIO" has no meaning in a foreign language.
Goods and ServicesGene and cell therapy medical services; medical consultant services in the fields of gene therapy and cell therapy
Disclaimer with Predetermined Text"THERAPEUTICS"
Goods and ServicesPharmaceutical research and development services in the fields of gene therapy and cell therapy; medical and pharmaceutical research and development services, all in the fields of gene therapy and cell therapy; research services relating to pharmaceutical products for gene and cell therapy; biochemistry research services relating to cell therapy and gene therapy

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, June 24, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, June 24, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, June 24, 2022
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCIMEIO THERAPEUTICS AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameCIMEIO THERAPEUTICS AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameCIMEIO THERAPEUTICS AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events


Event DateEvent Description
Tuesday, April 2, 2024FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, April 2, 2024FINAL DISPOSITION PROCESSED
Tuesday, March 19, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, December 19, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, December 19, 2023REGISTERED-PRINCIPAL REGISTER
Monday, December 18, 2023NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, November 29, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, November 29, 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, October 4, 2023NOTIFICATION PROCESSED BY IB
Tuesday, October 3, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 3, 2023PUBLISHED FOR OPPOSITION
Wednesday, September 13, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, September 13, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, September 13, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, August 28, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 17, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 16, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 16, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 10, 2023REFUSAL PROCESSED BY IB
Saturday, April 15, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, April 14, 2023REFUSAL PROCESSED BY MPU
Friday, February 24, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, February 23, 2023NON-FINAL ACTION WRITTEN
Wednesday, February 22, 2023NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Saturday, February 18, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, February 17, 2023NON-FINAL ACTION WRITTEN
Friday, February 10, 2023ASSIGNED TO EXAMINER
Tuesday, June 28, 2022APPLICATION FILING RECEIPT MAILED
Friday, June 24, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 23, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB